Delivery Order SPE2DB22D1200-SPE2DB25FN4CP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,265.16 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30. The contract utilizes firm fixed price pricing and carries an ultimate completion date of August 26, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Atomoxetine is a non-stimulant medication used primarily in the treatment of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $634 to Amerisourcebergen Drug Corporation for 30 capsules of 40mg Atomoxetine HCl. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 24-25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a $179,450 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 40mg Atomoxetine HCl capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania, fulfilling the contract within a day of the start date on August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues delivery orders under various...
- The Defense Logistics Agency awarded a $215,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561437264 atomoxetine hydrochloride 40mg capsules. As the prime contractor, Amerisourcebergen will provide 30 capsules of the specified pharmaceutical product for performance at its facility in Conshohocken, Pennsylvania between July 7-10, 2023. The ordering agency, DLA, manages the procurement of medical supplies and equipment for the U.S. Department of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Atomoxetine 18mg tablets (30-count units) under a firm fixed-price contract valued at $2,854.91, with completion targeted for August 26, 2025. This non-set-aside competitive award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $479 to Amerisourcebergen Drug Corporation for 40mg atomoxetine hydrochloride capsules. As the prime contractor, Amerisourcebergen will deliver 30 capsules to an address in Conshohocken, Pennsylvania, with performance required between July 19-20, 2023. The parent company, Amerisourcebergen Corporation, will perform the work through its corporate office division. No major subcontractors or set aside...
- The Defense Logistics Agency awarded a $825.43 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561522980 Atomoxetine HCl 40 mg capsules, 30 count. The order is for a one day period of performance from July 17-18, 2023 to supply the pharmaceutical product. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $290,160 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 capsules of 25mg Atomoxetine HCl to be delivered to its Conshohocken, Pennsylvania facility by July 31, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for the attention deficit hyperactivity disorder medication supports DLA's mission to provide critical healthcare products and services to military...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN4CPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Atomoxetine HCL 40 mg capsules in quantities of 30 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing and a ceiling value of $1,996.53. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for Atomoxetine HCL—a medication commonly used for attention-deficit/hyperactivity disorder treatment—reflects the company's ongoing role in fulfilling federal medical supply needs through the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/29/25 |